IFCC – WorldLab 2017

European Congress of the International Federation of Clinical Chemistry and Laboratory Medicine

Sebia/Ilex’s booth number: 63 - 64

Location: Durban International Convention Center

For more infos: IFCC Durban 2017


Sebia Workshop

Tuesday, October 24th - From 15:15 to 16:15

Room number: Conference room 2

“Medical added value of a Hb A1c separation technique for better management of diabetes patients

Diabetes mellitus is a global health burden. Approximately 8.8% of the world adult population is estimated to have diabetes. Diagnosis and follow-up of this metabolic disorder can be performed by measuring Hb A1c, one of the glycated fractions of hemoglobin A. As the red blood cell lifespan averages 120 days, Hb A1c is an index of mean glycemia during the preceding 8-12 weeks. At the same time, hemoglobinopathies (hemoglobin variants, thalassemias) are also highly prevalent across the world. Around 7% of the population are carriers of a hemoglobin disorder. Alpha-thalassemia, beta-thalassemia, Hb AS, Hb AC, Hb AD and Hb AE are the most prevalent conditions.
The presence of a hemoglobin disorder can be problematic when measuring Hb A1c: red blood cell lifespan can be altered and therefore can affect the clinical significance of the Hb A1c value. Current methods in use, such as immunoassay or boronate affinity chromatography, although considered accurate, are limitated by an inability to indicate the presence of an abnormal hemoglobin component.
The Sebia Capillarys Hb A1c assay using capillary electrophoresis (Hb A1c CE) has been filling this unmet laboratory need worldwide for several years, by separating hemoglobin fractions while providing accurate Hb A1c results

MODERATOR: David B. SACKS, NGSP Steering Committee, USA

"Comparing detection of Hb disorders by immunoassay and capillary electrophoresis during Hb A1c measurement: impact on reporting results"

  • Marita du PLESSIS
    • Chemical Pathologist at NRL Autolab - AMPATH, Centurion, South Africa


"Medical added value of reported hemoglobinopathies when interpreting Hb A1c: a clinician perspective"

  • Naomi LEVITT
    • Head of Diabetic Medicine and Endocrinology at Groote Schuur Hospital and University of Cape Town, South Africa

For more information

Use our contact form